Visible particulates in injections - A history and a proposal to revise USP general chapter injections [1]

Pharmacopeial Forum

Volumn 35, Issue 5, 2009, Pages 1383-1387

  Madsen, Russell E ^c   Cherris, Roy T ^c   Shabushnig, John G ^c   Hunt, Desmond G ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNITED STATES PHARMACOPEIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CONTAMINATION; DRUG INDUSTRY; DRUG SOLUTION; EMBOLISM; FOOD AND DRUG ADMINISTRATION; FOREIGN BODY; GRANULOMA; HEALTH CARE PRACTICE; HUMAN; INJECTION SITE; MEDICAL LITERATURE; MICROBIAL CONTAMINATION; NONHUMAN; PARENTERAL DRUG ADMINISTRATION; PARTICULATE MATTER; PROCESS DESIGN; QUALITY CONTROL; REVIEW; RISK ASSESSMENT;

EID: 70349734712     PISSN: 03634655     EISSN: 15421945     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Shabushnig JG, Melchore JA, Geiger M, Chrai S, Gerger ME. A proposed working standard for validation of particulate inspection in sterile solutions. Paper presented at: DIA Annual Meeting; 1994; Philadelphia, PA.
2. Brewer JH, Dunning JHF. An in vitro and in vivo study of glass particles in ampules. J Am Pharm Assoc. 1947;36:289-293.
3. Schoenberg MD, Gillman PA, Mumaw V, Moore RD. Proliferation of the reticuloendothial system and phagocytosis. Exp MoI Pathol. 1963;2:126.
4. Hozumi K, Kitamura K, Kitade T, Iwagami S. Localization of glass particles in animal organs derived from cutting of glass ampoules before intravenous injection. Microchemical J. 1983;28:215.
5. Brekkan A, Lexow PE, Woxholt G. Glass fragments and other particles contaminating contrast media. Acta Radiol. 1975;16:600.
6. Parikh MJ, Dumas G, Silvestri A, Bistrian BR, Driscoll DF. Physical compatibility of neonatal total parenteral nutrient admixtures containing organic calcium and inorganic phosphate salts. Am J Health-Syst Pharm. 2005;62:1177-1183. (Pubitemid 40741057)
7. Newton DW, Driscoll DF. Calcium and phosphate compatibility: revisited again. Am j Health-Syst Pharm. 2008;65:73-80.
8. Thomas WH, Lee YK. Particles in intravenous solutions. N Z Med J. 1974;80:170.
9. Borchert SJ, Abe A, Aldrich DS, Fox LE, Freeman JE, White RD. Particulate matter in parenteral products: a review. J Parenter Sci Technol. 1986;40:212.
10. Turco S, Davis NM. Clinical significance of particulate matter: a review of the literature. Hosp Pharm. 1973;8:137.
11. Groves MJ, deMalka SR. The relevance of pharmacopeial particulate matter tests. Drug Dev Commun. 1976;2:285.
12. Groves MJ. Parenteral Products: The Preparation and Quality Control of Products for Injection. London, UK: Heinemann Medical Books; 1973.
13. Groves MJ. Particulate Matter: Sources and Resources for Healthcare Manufacturers. Buffalo Grove, Illinois: Interpharm Press; 1993.
14. Garvin JM, Gunner BW. Intravenous fluids: a solution containing such particles must not be used. Med J Aust. 1963;2:140.
15. Garvin JM, Gunner BW. The harmful effects of particles in intravenous fluids. Med j Aust. 1964;2:1.
16. Burton JF, Zawadzki ES, Wetherell HR, Moy TW. Mainliners and blue velvet. J Forensic Sci. 1965;10:466.
17. Richman S, Harris RD. Acute pulmonary edema associated with Librium abuse. Radiol. 1972;103:57.
18. Douglas FG. Foreign particle embolism in drug addicts: respiratory pathophysiology. Ann Intern Med. 1971;75:865.
19. Injectable Drug Delivery: Probing the Route to Growth. Datamonitor, January 2004.
20. American Pharmaceutical Association. NF VII. Washington, DC: American Pharmaceutical Association; 1942.
21. USP. USP XII. Philadelphia, PA: Mack Publishing; 1942.
22. USP. USP XIII. Philadelphia, PA: Mack Publishing; 1947.
23. Kleinfeld VA, Dunn CW. United States vs Bristol Labs., Inc. Federal Food Drug and Cosmetic Act: judicial and Administrative Record. 1938-1949;310-314.
24. Pflag SC. Large volume parenteral solutions procured by the military. Paper presented at: FDA National Symposium, Safety of Large Volume Parenteral Solutions; July 28-29; 1968.
25. USP. USP XIX, Supplement 1. Rockville, MD: USP; 1975.
26. USP. USP XX. Rockville, MD: USP; 1980.
27. USP. USP XXIII. Rockville, MD: USP; 1995.
28. USP. USP XIV. Rockville, MD: USP; 1971.
29. USP. USP 31. Rockville, MD: USP; 2008.
30. Japanese Pharmacopoeia. Japanese Pharmacopoeia, Fifteenth Edition, General Rules for Preparations, 11. Injections. Tokyo, Japan: Japanese Pharmacopoeia; 2006:11.
31. European Medicines Evaluation Agency. European Pharmacopoeia 6.0, Parenteral Preparations, Injections, European Directorate for the Quality of Medicines & Healthcare. Strasbourg, France: EMEA; 2008:736.
32. Leversee RL, Shabushnig JG. A survey of industry practice for the visual inspection of injectable products (preliminary report). Paper presented at: PDA Visual Inspection Forum; 2008; Berlin, Germany.
33. ANSI/ASQ. Z1.4-2003 Sampling Procedures and Tables for Inspection by Attributes. American Society for Quality. Milwaukee, WI: ASQ; 2003.